188 related articles for article (PubMed ID: 2497766)
1. The effect of carbamazepine on valproic acid disposition in adult volunteers.
Panesar SK; Orr JM; Farrell K; Burton RW; Kassahun K; Abbott FS
Br J Clin Pharmacol; 1989 Mar; 27(3):323-8. PubMed ID: 2497766
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine/valproic acid interaction in man and rhesus monkey.
Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P
Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944
[TBL] [Abstract][Full Text] [Related]
3. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.
Macphee GJ; Mitchell JR; Wiseman L; McLellan AR; Park BK; McInnes GT; Brodie MJ
Br J Clin Pharmacol; 1988 Jan; 25(1):59-66. PubMed ID: 3130892
[TBL] [Abstract][Full Text] [Related]
4. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding.
Mattson GF; Mattson RH; Cramer JA
Ther Drug Monit; 1982; 4(2):181-4. PubMed ID: 6808714
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.
Rakic Ignjatovic A; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
Br J Clin Pharmacol; 2009 Feb; 67(2):199-208. PubMed ID: 19076986
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
[TBL] [Abstract][Full Text] [Related]
7. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
[TBL] [Abstract][Full Text] [Related]
8. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
9. Interactions of valproic acid with carbamazepine and its metabolites' concentrations, concentrations ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR; Browne RH
Clin Neuropharmacol; 1995 Feb; 18(1):1-12. PubMed ID: 8665529
[TBL] [Abstract][Full Text] [Related]
10. Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.
Battino D; Croci D; Granata T; Bernardi G; Monza G
Ther Drug Monit; 1992 Oct; 14(5):376-9. PubMed ID: 1448844
[TBL] [Abstract][Full Text] [Related]
11. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Steinborn B; Galas-Zgorzalewicz B
Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
[TBL] [Abstract][Full Text] [Related]
12. Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients.
McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
Epilepsy Res; 1992 May; 11(3):193-8. PubMed ID: 1396534
[TBL] [Abstract][Full Text] [Related]
13. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
Suemaru K; Kawasaki H; Yasuhara K; Yao K; Furuno K; Kawakami Y; Araki H; Gomita Y; Oka E
Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740
[TBL] [Abstract][Full Text] [Related]
14. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study.
Pisani F; Caputo M; Fazio A; Oteri G; Russo M; Spina E; Perucca E; Bertilsson L
Epilepsia; 1990; 31(3):339-42. PubMed ID: 2111769
[TBL] [Abstract][Full Text] [Related]
15. Effects of anticonvulsants on plasma levels and entero-hepatic circulation of valproic acid and on hepatic drug metabolizing enzyme activities in rats.
Ogiso T; Ito Y; Iwaki M; Yoneda I; Horibe Y
J Pharmacobiodyn; 1989 May; 12(5):255-63. PubMed ID: 2509672
[TBL] [Abstract][Full Text] [Related]
16. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.
Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P
Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269
[TBL] [Abstract][Full Text] [Related]
17. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.
Blanco-Serrano B; Otero MJ; Santos-Buelga D; García-Sánchez MJ; Serrano J; Domínguez-Gil A
Biopharm Drug Dispos; 1999 Jul; 20(5):233-40. PubMed ID: 10594867
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine but not valproate induces bupropion metabolism.
Ketter TA; Jenkins JB; Schroeder DH; Pazzaglia PJ; Marangell LB; George MS; Callahan AM; Hinton ML; Chao J; Post RM
J Clin Psychopharmacol; 1995 Oct; 15(5):327-33. PubMed ID: 8830063
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
20. Derivation and evaluation of an equation for prediction of free carbamazepine concentrations in patients comedicated with valproic acid.
Haidukewych D; Zielinski JJ; Rodin EA
Ther Drug Monit; 1989 Sep; 11(5):528-32. PubMed ID: 2510373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
